Kate has more than ten years of research experience in the life sciences, with over half of these working closely with pharmaceutical and biotech clients. At Healogix, Kate leads complex domestic and global research projects from start to finish across all major therapeutic areas as well as orphan diseases. She has extensive experience with a range of methodologies, data analysis, and synthesizing insights into actionable findings.
Kate is especially skilled at leading market tracking studies as well as engagements involving patient-based discrete choice with the primary goal of cutting through the complexity to provide clients with succinct yet comprehensive deliverables. What sets Kate apart is her focus on forming strong partnerships with clients which allows her to provide a greater depth of knowledge and better leverage existing information across engagements.
Prior to joining Healogix, Kate spent over five years in a consultative capacity supporting specialized research services at Rutgers University. Kate earned both her BS and MBA from Rutgers University in New Jersey.